Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- N/A
Related studies linked through entity extraction aliases.